Vertex Pharmaceuticals Inc (VX1.HM)
Hamburg - Hamburg Delayed price. Currency in EUR
Add to watchlist
As of 08:01AM CEST. Market open.
| Previous close | 374.50 |
| Open | 381.15 |
| Bid | 394.45 x 0 |
| Ask | 394.80 x 0 |
| Day's range | 381.15 - 381.15 |
| 52-week range | 300.00 - 407.10 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 Jul 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Vertex Pharmaceuticals First Quarter 2024 Earnings: Beats Expectations
Vertex Pharmaceuticals ( NASDAQ:VRTX ) First Quarter 2024 Results Key Financial Results Revenue: US$2.69b (up 13% from...
Investor's Business DailyVertex's Pain Drug Could Be Worth Up To $11.4 Billion — Ongoing Debate Sparks Shares
Vertex stock advanced Tuesday as analysts debated the company's pain drug with one saying it could eventually generate $11.4 billion in sales.
Insider MonkeyVertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]
© 2024 Yahoo. All rights reserved.